Log In
BCIQ
Print this Print this
 

SB-756050

Also known as: 756050

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionBile acid receptor agonist
Molecular Target Farnesoid X receptor (FXR) (NR1H4)
Mechanism of ActionFarnesoid X receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today